Marisa Pautasso

Deferasirox is a powerful NF- B inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavenging

Emanuela Messa, Sonia Carturan, Chiara Maffè et al. · Haematologica · 2010 · 131 citations · Full text

Medicine, Hematology, Pharmacology +17

The NF-κB pathway blockade by the IKK inhibitor PS1145 can overcome Imatinib resistance

Daniela Cilloni, F. Messa, Francesca Arruga et al. · Leukemia · 2005 · 122 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

Increase in platelet count in older, poor‐risk patients with acute myeloid leukemia or myelodysplastic syndrome treated with valproic acid and all‐trans retinoic acid

Chiara Pilatrino, Daniela Cilloni, Emanuela Messa et al. · Cancer · 2005 · 100 citations · Full text

Medicine, Hematology, Pharmacology +16

Effects of Src kinase inhibition induced by dasatinib in non–small cell lung cancer cell lines treated with cisplatin

Paolo Ceppi, Mauro Papotti, Valentina Monica et al. · Molecular Cancer Therapeutics · 2009 · 56 citations · Full text

Medicine, Cancer Biology, Pharmacology +17

NF‐kB inhibition as a strategy to enhance etoposide‐induced apoptosis in K562 cell line

Alessandro Morotti, Daniela Cilloni, Marisa Pautasso et al. · American Journal of Hematology · 2006 · 52 citations · Full text

Life Sciences, Oncology, Pharmacology +17